These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25386813)

  • 21. Impact of the introduction of rituximab in first-line follicular lymphoma: a retrospective study of 247 unselected patients referred to a single institution with a long-term follow-up.
    Nicolas-Virelizier E; Ségura-Ferlay C; Ghesquières H; Chassagne-Clément C; Gargi T; Biron P; Belhabri A; Rey P; Faurie P; Chabaud S; Sebban C
    Hematol Oncol; 2015 Mar; 33(1):1-8. PubMed ID: 24496668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating relapsed follicular lymphoma.
    Erblich T; Montoto S
    Expert Rev Hematol; 2018 May; 11(5):403-410. PubMed ID: 29542329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rituximab therapy for follicular lymphoma: a comprehensive review of its efficacy as primary treatment, treatment for relapsed disease, re-treatment and maintenance.
    Cohen Y; Solal-Céligny P; Polliack A
    Haematologica; 2003 Jul; 88(7):811-23. PubMed ID: 12857561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follicular lymphoma: 2012 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2012 Oct; 87(10):988-95. PubMed ID: 23001911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status and perspective of antibody therapy in follicular lymphoma.
    Buske C; Weigert O; Dreyling M; Unterhalt M; Hiddemann W
    Haematologica; 2006 Jan; 91(1):104-12. PubMed ID: 16434378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of indolent lymphoma in Germany - results of a representative population-based survey.
    Schmidt C; Fetscher S; Görg C; Kornek P; Nusch A; Kegel T; Kellermann L; Hiddemann W; Fingerle-Rowson G; Dreyling M
    Clin Lymphoma Myeloma Leuk; 2011 Apr; 11(2):204-11. PubMed ID: 21575925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current immunochemotherapy strategies in follicular lymphoma.
    Giné E; Gutiérrez-García G; López-Guillermo A
    Adv Ther; 2010 Oct; 27(10):704-13. PubMed ID: 20820973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follicular lymphoma: the case for timely intervention.
    McLaughlin P
    Expert Rev Hematol; 2009 Jun; 2(3):277-84. PubMed ID: 21082969
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular Lymphoma: Recent and Emerging Therapies, Treatment Strategies, and Remaining Unmet Needs.
    Matasar MJ; Luminari S; Barr PM; Barta SK; Danilov AV; Hill BT; Phillips TJ; Jerkeman M; Magagnoli M; Nastoupil LJ; Persky DO; Okosun J
    Oncologist; 2019 Nov; 24(11):e1236-e1250. PubMed ID: 31346132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current treatment for malignant lymphomas].
    Usui N
    Gan To Kagaku Ryoho; 2007 Dec; 34(13):2191-9. PubMed ID: 18079619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follicular lymphoma: current management and future directions.
    Bello C; Zhang L; Naghashpour M
    Cancer Control; 2012 Jul; 19(3):187-95. PubMed ID: 22710894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current standard treatments and future outlook for follicular lymphoma].
    Maruyama D
    Rinsho Ketsueki; 2024; 65(9):1004-1011. PubMed ID: 39358254
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How we manage follicular lymphoma.
    Hiddemann W; Cheson BD
    Leukemia; 2014 Jul; 28(7):1388-95. PubMed ID: 24577532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.
    Sarkozy C; Baseggio L; Feugier P; Callet-Bauchu E; Karlin L; Seymour JF; Lebras L; Michallet AS; Offner F; Dumas O; Traverse-Glehen A; Ffrench M; Lopez-Guillermo A; Berger F; Coiffier B; Felman P; Salles G
    Br J Haematol; 2014 Mar; 164(5):659-67. PubMed ID: 24274024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction of rituximab in front-line and salvage therapies has improved outcome of advanced-stage follicular lymphoma patients.
    Sacchi S; Pozzi S; Marcheselli L; Bari A; Luminari S; Angrilli F; Merli F; Vallisa D; Baldini L; Brugiatelli M;
    Cancer; 2007 May; 109(10):2077-82. PubMed ID: 17394190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin's lymphoma.
    Boland A; Bagust A; Hockenhull J; Davis H; Chu P; Dickson R
    Health Technol Assess; 2009 Sep; 13 Suppl 2():41-8. PubMed ID: 19804688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical features of gastrointestinal follicular lymphoma: comparison with nodal follicular lymphoma and gastrointestinal MALT lymphoma.
    Tari A; Asaoku H; Kunihiro M; Tanaka S; Fujihara M; Yoshino T
    Digestion; 2011; 83(3):191-7. PubMed ID: 21266815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The therapeutic use of rituximab in non-Hodgkin's lymphoma.
    Marcus R; Hagenbeek A
    Eur J Haematol Suppl; 2007 Jan; (67):5-14. PubMed ID: 17206982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: results of the National LymphoCare Study.
    Martin P; Byrtek M; Dawson K; Ziemiecki R; Friedberg JW; Cerhan JR; Flowers CR; Link BK
    Cancer; 2013 Dec; 119(23):4129-36. PubMed ID: 24006156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is the role of maintenance rituximab in follicular NHL?
    Maloney DG
    Oncology (Williston Park); 2008 Jan; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.